CY1153A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- CY1153A CY1153A CY1153A CY115376A CY1153A CY 1153 A CY1153 A CY 1153A CY 1153 A CY1153 A CY 1153A CY 115376 A CY115376 A CY 115376A CY 1153 A CY1153 A CY 1153A
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2520978A DE2520978C3 (de) | 1975-05-10 | 1975-05-10 | Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1153A true CY1153A (en) | 1982-09-10 |
Family
ID=5946306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY1153A CY1153A (en) | 1975-05-10 | 1976-05-10 | Pharmaceutical compositions |
Country Status (12)
Country | Link |
---|---|
US (1) | US4189469A (ja) |
AU (1) | AU502644B2 (ja) |
BE (1) | BE841617A (ja) |
CY (1) | CY1153A (ja) |
DE (1) | DE2520978C3 (ja) |
DK (1) | DK153918C (ja) |
FR (1) | FR2310764A1 (ja) |
GB (1) | GB1547232A (ja) |
HK (1) | HK42382A (ja) |
KE (1) | KE3219A (ja) |
MY (1) | MY8600617A (ja) |
ZA (1) | ZA762748B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4491539A (en) * | 1981-06-04 | 1985-01-01 | The Procter & Gamble Company | Liquid cleansing product with skin feel additives |
DE3127237A1 (de) * | 1981-07-10 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung |
US4636507A (en) * | 1984-04-30 | 1987-01-13 | Hoechst-Roussel Pharmaceuticals Inc. | Host defense mechanism enhancement |
DE3508097A1 (de) * | 1984-07-21 | 1986-02-06 | Hoechst Ag, 6230 Frankfurt | Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung |
EP0222883A1 (en) * | 1985-05-15 | 1987-05-27 | Riker Laboratories, Inc. | Sustained release theophylline compositions and processes |
GB8628359D0 (en) * | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
US5200193A (en) * | 1987-04-22 | 1993-04-06 | Mcneilab, Inc. | Pharmaceutical sustained release matrix and process |
US4820522A (en) * | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
US5085865A (en) * | 1989-04-12 | 1992-02-04 | Warner-Lambert Company | Sustained release pharmaceutical preparations containing an analgesic and a decongestant |
US5112827A (en) * | 1990-05-18 | 1992-05-12 | Board Of Regents, The University Of Texas System | Drug to reverse fatty liver and atheromatous lesions |
FR2677886B1 (fr) * | 1991-06-18 | 1995-03-31 | Adir | Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale. |
US5498802A (en) * | 1995-02-28 | 1996-03-12 | Hoechst Celanese Corporation | Process for preparing omega-halo-ketones |
US20040209900A1 (en) * | 2003-04-15 | 2004-10-21 | Hauptman Stephen P. | Treatment of lipodystrophy (lipid redistribution syndrome) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3065143A (en) * | 1960-04-19 | 1962-11-20 | Richardson Merrell Inc | Sustained release tablet |
US3864469A (en) * | 1967-12-16 | 1975-02-04 | Hoechst Ag | Xanthines in pharmaceutical preparations and for stabilization of vitamins |
DE1617418C3 (de) * | 1967-12-16 | 1980-01-24 | Hoechst Ag, 6000 Frankfurt | Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe |
US3577514A (en) * | 1968-06-10 | 1971-05-04 | Pfizer | Sustained release pharmaceutical tablets |
US3590117A (en) * | 1969-03-24 | 1971-06-29 | Richardson Merrell Inc | Long-lasting troche containing guar gum |
US3639169A (en) * | 1969-04-29 | 1972-02-01 | Sucrest Corp | Direct compression vehicles and method therefor |
-
1975
- 1975-05-10 DE DE2520978A patent/DE2520978C3/de not_active Expired
-
1976
- 1976-05-06 US US05/683,795 patent/US4189469A/en not_active Expired - Lifetime
- 1976-05-07 FR FR7613720A patent/FR2310764A1/fr active Granted
- 1976-05-07 ZA ZA762748A patent/ZA762748B/xx unknown
- 1976-05-07 BE BE166873A patent/BE841617A/xx not_active IP Right Cessation
- 1976-05-07 DK DK205376A patent/DK153918C/da not_active IP Right Cessation
- 1976-05-10 GB GB19162/76A patent/GB1547232A/en not_active Expired
- 1976-05-10 AU AU13765/76A patent/AU502644B2/en not_active Expired
- 1976-05-10 CY CY1153A patent/CY1153A/xx unknown
-
1982
- 1982-07-07 KE KE3219A patent/KE3219A/xx unknown
- 1982-09-30 HK HK423/82A patent/HK42382A/xx unknown
-
1986
- 1986-12-30 MY MY617/86A patent/MY8600617A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MY8600617A (en) | 1986-12-31 |
HK42382A (en) | 1982-10-08 |
DK205376A (da) | 1976-11-11 |
DK153918B (da) | 1988-09-26 |
BE841617A (fr) | 1976-11-08 |
DE2520978A1 (de) | 1976-11-18 |
DK153918C (da) | 1989-02-06 |
FR2310764B1 (ja) | 1980-07-11 |
KE3219A (en) | 1982-08-13 |
AU502644B2 (en) | 1979-08-02 |
DE2520978C3 (de) | 1981-02-19 |
FR2310764A1 (fr) | 1976-12-10 |
DE2520978B2 (de) | 1980-06-12 |
US4189469A (en) | 1980-02-19 |
AU1376576A (en) | 1977-11-17 |
ZA762748B (en) | 1977-04-27 |
GB1547232A (en) | 1979-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA7671B (en) | Pharmaceutical composition | |
JPS5272829A (en) | Pharmaceutical composition | |
JPS51150560A (en) | Filmmforming compositions | |
JPS51150561A (en) | Filmmforming compositions | |
ZA763917B (en) | Pharmaceutical compositions and compounds | |
ZA762748B (en) | Pharmaceutical compositions | |
GB1538554A (en) | Hydrocurable compositions | |
GB1548675A (en) | Odiurant compositions | |
NZ181503A (en) | Substituted diphenyls-ulphides and pharmaceutical compositions | |
NZ182591A (en) | 14-substituted-daunorubicins and pharmaceutical compositions | |
GB1549326A (en) | Sunprotective compositions | |
NZ182581A (en) | -amino-ketones and pharmaceutical compositions | |
NZ181864A (en) | Noroxymorphones and pharmaceutical compositions | |
PT65171A (en) | Match-head compositions | |
JPS5232924A (en) | Soluvent compositions | |
GB1539031A (en) | Pharmaceutical compositions | |
ZA767215B (en) | Pharmaceutical compositions | |
GB1552416A (en) | Pharmaceutical compositions | |
ZA761880B (en) | New pharmaceutical compositions | |
JPS5271552A (en) | Compositions | |
ZA763806B (en) | Pharmaceutical compositions | |
PH11642A (en) | Benzocycloheptothiophenes and pharmaceutical compositions | |
PT64948B (en) | Compositions | |
IE43955L (en) | Pharmaceutical composition | |
IL51043A0 (en) | Novel pharmaceutical compositions comprising ergot-type compounds |